Related Experiment Videos
Snake and spider antivenin: risks and benefits of therapy
R S Weisman1, S S Lizarralde, V Thompson
1Pediatrics, University of Miami School of Medicine, Florida, USA.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Risk of hemoptysis in cystic fibrosis clinical trials: A retrospective cohort study.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2015
Tumourigenic canine osteosarcoma cell lines associated with frizzled-6 up-regulation and enhanced side population cell frequency.
Veterinary and comparative oncology·2015
Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2014
Canine osteosarcoma cell lines from patients with differing serum alkaline phosphatase concentrations display no behavioural differences in vitro.
Veterinary and comparative oncology·2013
Activation of the canonical Wnt/β-catenin signalling pathway is rare in canine malignant melanoma tissue and cell lines.
Journal of comparative pathology·2012
Nutrition recommendations and principles for people with diabetes mellitus. American Diabetes Association.
The Journal of the Florida Medical Association·1998
Changes in profiles of students admitted to Florida allopathic medical schools 1990-1996.
The Journal of the Florida Medical Association·1998
Layered classification in Parkinson's disease: a content analysis of clinical, prodromal, and biological criteria evolution.
Frontiers in aging neuroscience·2026
Successful management of trichotillomania in a patient with SSRI-induced hypersomnia: a case report.
Frontiers in psychiatry·2026
Schiff Bases as Multifunctional Agents in Parkinson's Disease Therapy: A Comprehensive Review.
Mini reviews in medicinal chemistry·2026
In vitro assessments for pharmacokinetic drug-drug interaction potential of vornorexant, a novel dual orexin 1/2 receptor antagonist.
Xenobiotica; the fate of foreign compounds in biological systems·2026
Secondary Pharmacology Targets for Pediatric Developmental Safety Assessment of New Drugs: Clinical Pharmacology Considerations.
Clinical pharmacology and therapeutics·2026
From Pathogenesis to Therapy: Extracellular Vesicles Orchestrate Cellular Crosstalk in Acetaminophen Hepatotoxicity.
European journal of pharmacology·2026